At Nado Health, we believe that any individual has a right to evaluate and control their own health.
Our job is to make it easier.
Creating Clinical Systems
Around the world the access to medical care and resources involved are not evenly distributed.
Challenges
1. Time and Resource Constraints:
Limited budgets and staff availability.
2. Infrastructural Challenges:
Lack of infrastructure to support digital solutions.
3. Regulatory Hurdles:
Compliance barriers preventing integration.
Solution
1. Easy Deployment:
Seamless integration and intuitive interface.
2. Low Cost Deployment:
Adapted to existing resources.
3. Seamless Regulatory Integration:
The solution is designed to not compromise existing IT/Infrastructure, minimizing technical risk and simplifying the path to regulatory compliance and integration.
We make modern healthcare accessible to all—bridging legacy tools like paper and fax with next-generation digital technology in one secure, affordable platform that empowers patients and simplifies care.
Case Study: Japan's Health Gap
Despite high levels of development, Japan faces dangerously low rates of preventative health screening, particularly for STDs and cervical cancer. This creates a public health risk that is worsened by significant social, financial, and logistical barriers that prevent individuals from easily accessing necessary diagnostic tests.
Syphilis infection rate
Sources: [1] Cervical Cancer plot: 左図:20~69歳女性の子宮頸がん検診受診率の比較. OECE Stat Web Browser. Organization for Economic Co-operation and Development, Health care utilisation (2021) URL: https://stats.oecd.org/Index.aspx?QueryId=30159 [Last Accessed 2024 Feb 17]; [2]Syphilis Chart: NIID chart 1: https://www.niid.go.jp/niid/images/iasr/2023/12/526r08f01.gif from 国立感染症研究所(NIID)「感染症発生動向調査における近年の梅毒の動向―2023年第1週~39週診断例を中心に―」(IASR Vol. 44: 2023年12月号) URL: https://www.niid.go.jp/niid/ja/typhi-m/iasr-reference/2617-related-articles/related-articles-526/12419-526r08.html [Last Accessed: 17 Feb 2024]
Key Access Barriers in Japan
For women in Japan seeking sexually transmitted disease (STD) and gender-specific tests, access to necessary diagnostics is significantly restricted by four key factors.
These include Time, due to limited clinic hours and lengthy appointment or wait times, and high Price, resulting from high out-of-pocket costs for screening exams not covered by health insurance. Furthermore, logistical challenges arise from Test Availability, where there is uncertainty about whether a clinic will actually perform the required tests, and social barriers exist due to the need for Doctor's Permission, which often necessitates potentially stressful personal explanations to secure testing.
Our Product
Nado Health partners with local clinics and laboratories in Japan to digitally streamline health testing, offering a crucial service that complements existing diagnostic and treatment care.
Our model is designed to eliminate the common barriers of time, cost, and privacy by handling the entire administrative and logistical process for simple "test-only" requests without doctor involved.
Through the Nado Health app, patients can quickly find, book, and pay for services—with sampling completed in under 20 minutes and results delivered within 36 hours, all without the need for stressful personal explanations.
This unique approach allows medical professionals to focus on complex patient care, while Nado Health empowers individuals with faster, more affordable, and completely discreet access to their health information.
If you feel there is a need for such service in your country:
If you are in Japan and would like to learn more about our service, please refer to our Japanese website:
Other services
Beyond our core solutions, Nado Health provides B2B consulting and AI-powered digital tools to streamline bookings, automate lab and data workflows, and improve patient communication—helping your clinic operate smarter and more efficiently.
Company Information
Name: Nado Health K.K.
Head Office: 403, Tensho Yoyogi ANNEX Building, 1-30-14 Yoyogi, Shibuya-ku, Tokyo
Phone Number: +81 (0)90-5860-8321
CEO: Maria Astrakhan